Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis

Journal of Immunology

Volumn 174, Issue 5, 2005, Pages 3067-3071

  Rolland, Alexandre ^a   Guyon, Lydie ^a   Gill, Michelle ^b   Cai, Yi Hong ^c   Banchereau, Jacques ^a   McClain, Kenneth ^c   Palucka, A Karolina ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; DENDRITIC CELL POIETIN; FLT3 LIGAND; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE LESION; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; HIGH RISK PATIENT; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; MACROPHAGE; MYELOID PROGENITOR CELL; PATHOGENESIS; PRIORITY JOURNAL; SKIN DISEASE;

EID: 14044270749     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.5.3067     Document Type: Article

References (35)

1. McClain, K., J. Hutter, and J. Cassady. 1994. Langerhans cell histiocytosis. Radiation Therapy in Pediatric Oncology. J. R. Cassady, ed. Springer-Verlag, New York, p. 337.
2. Geissmann, F., Y. Lepelletier, S. Fraitag, J. Valladeau, C. Bodemer, M. Debre, M. Leborgne, S. Saeland, and N. Brousse. 2001. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97:1241.
3. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480.
4. Randolph, G. J., K. Inaba, D. F. Robbiani, R. M. Steinman, and W. A. Muller. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753.
5. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:510.
6. Peters, J. H., H. Xu, J. Ruppert, D. Ostermeier, D. Friedrichs, and R. K. Gieseler. 1993. Signals required for differentiating dendritic cells from human monocytes in vitro. Adv. Exp. Med. Biol. 329:275.
7. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
8. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
9. Paquette, R. L., N. C. Hsu, S. M. Kiertscher, A. N. Park, L. Tran, M. D. Roth, and J. A. Glaspy. 1998. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukocyte Biol. 64:358.
10. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947.
11. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777.
12. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294:1540.
13. Chomarat, P., C. Dantin, L. Bennett, J. Banchereau, and A. K. Palucka. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171:2262.
14. Mohamadzadeh, M., F. Berard, G. Essert, C. Chalouni, B. Pulendran, J. Davoust, G. Bridges, A. K. Palucka, and J. Banchereau. 2001. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194:1013.
15. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165:566.
16. Robinson, S. P., S. Patterson, N. English, D. Davies, S. C. Knight, and C. D. Reid. 1999. Human peripheral blood contains two distinct lineages of dendritic cells. Eur. J. Immunol 29:2769.
17. Lyman, S. D., and S. E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101.
18. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:2222.
19. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
20. Maraskovsky, E., E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack, and H. J. McKenna. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878.
21. Gill, M. A., P. Blanco, E. Arce, V. Pascual, J. Banchereau, and A. K. Palucka. 2002. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63:1172.
22. Willman, C. L., L. Busque, B. B. Griffith, B. E. Favara, K. L. McClain, M. H. Duncan, and D. G. Gilliland. 1994. Langerhans-cell histiocytosis (histiocytosis X): a clonal proliferative disease. N. Engl. J. Med. 331:154.
23. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-β1 prevents the non-cognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567.
24. Egeler, R. M., B. E. Favara, M. van Meurs, J. D. Laman, and E. Claassen. 1999. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94:4195.
25. Egeler, R. M., B. E. Favara, J. D. Laman, and E. Claassen. 2000. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Cancer 36:2105.
26. Gadner, H., N. Grois, M. Arico, V. Broadbent, A. Ceci, A. Jakobson, D. Komp, J. Michaelis, S. Nicholson, U. Potschger, J. Pritchard, and S. Ladisch. 2001. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J. Pediatr. 138:728.
27. Bazan, J. F. 1991. Genetic and structural homology of stem cell factor and macrophage colony-stimulating factor. Cell 65:9.
28. Stanley, E. R., L. J. Guilbert, R. J. Tushinski, and S. H. Bartelmez. 1983. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J. Cell Biochem. 21:151.
29. Eubank, T. D., M. Galloway, C. M. Montague, W. J. Waldman, and C. B. Marsh. 2003. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol. 171:2637.
30. Hershey, C. L., and D. E. Fisher. 2004. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone 34:689.
31. Takahashi, K., M. Naito, and L. D. Shultz. 1992. Differentiation of epidermal Langerhans cells in macrophage colony-stimulating-factor-deficient mice homozygous for the osteopetrosis (op) mutation. J. Invest. Dermatol. 99:46S.
32. + cells differentiate into dermal dendritic cells in co-culture with cutaneous fibroblasts or stromal cells. J. Invest. Dermatol. 118:450.
33. + hematopoietic progenitor cells into Langerhans cells under serum-free conditions without granulocyte-macrophage colony-stimulating factor. J. Invest. Dermatol. 120:256.
34. Rivollier, A., M. Mazzorana, J. Tebib, M. Piperno, T. Aitsiselmi, C. Rabourdin-Combe, P. Jurdic, and C. Servet-Delprat. 2004. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104:4029.
35. Barth, J., H. Kreipe, H. J. Radzun, K. Heidorn, W. Petermann, B. Bewig, and M. R. Parwaresch. 1991. Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X. Thorax. 46:835.